Follow us on Twitter @Michiganliver for the latest Michigan Hepatology news.
- A better approach to caring for cirrhosis - Elliot Tapper, MD and Neehar Parikh, MD, MS look at the existing gaps in care for individuals with cirrhosis and how to improve their quality of life.
- Jessica Mellinger, MD, MSc and team find that integrated, multidisciplinary management of alcohol-related liver disease is feasible and produced encouraging early outcomes. Click here to read the article in the Journal of Substance Abuse Treatment.
- Pratima Sharma, MD, MS conducted a phase 3 trial to confirm the efficacy and safety of terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. Click here to read the article in the New England Journal of Medicine.
- New study suggests excess glycogen may cause metabolic syndrome - Elizabeth Speliotes, MD, PhD, MPH led a team of experts to explore the possible association between genetic variants in the human genome and liver attenuation.
- Elliot Tapper, MD and Neehar Parikh, MD, MS analyzed national organ transplant data and found a wide variation in organ procurement organizations’ efficiency. Click here to read the article in JAMA Surgery.
- Anna Lok, MD reflects on progress fighting hepatitis C – and a path forward. The hepatitis C virus was discovered in 1989 – research that’s now earned a Nobel Prize.
- Are Organ Transplant Recipients at Greater Risk of Death from COVID-19? A new study analyzes death risk from COVID-19 in organ transplant recipients and finds one treatment method greatly increased the risk.
Archive
- Liver damage more commonly due to malignant tumors than cancer immunotherapy drug
- Anna Lok, MD appointed Distinguished University Professor
- A tiny cry for help from inside the liver could lead to better treatment
- Many popular dietary supplements can yield dangerous liver results
- New NCI-funded program targets early detection of liver cancer
- New simultaneous liver and kidney transplantation policy streamlines process
- Michigan Medicine at The Liver Meeting 2018
- Spike in hep C infections mutes thrill of recent cure
- Key protein discovery sheds light on fatty liver origins
- Alcohol-related cirrhosis deaths skyrocket in young adults
- Do's and don'ts in the management of cirrhosis: A view from the 21st century
- Fat hormone linked to progression of fatty liver disease may hold key to new treatments
- Dr. Anna Lok selected to receive the 2018 European Association for the Study of the Liver (EASL) International Recognition Award
- Michigan Medicine at The Liver Meeting 2017
